Breast Cancer Conferences, Cancer Conferences, World Congress on Breast Cancer, Breast Cancer Conferences, Breast Cancer Events, Women Healthcare conferences

Renowned Speakers

Elizabeth Andersen

University of British Columbia Canada

M.P. van den Tol

University Medical Center De Boelelaan Netherlands

Emmanuelle Charafe-Jauffret

University of Mediterranee France

Lidija Covic

Tufts Medical center USA

Marco Bernini

Careggi University Hospital Italy

Sunny Po

University of Oklahoma Health Sciences Center, USA

Issam A Mikati

Northwestern University USA

Maude Hebert

University of Quebec in Trois-Rivieres, Canada

Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK

Pharma Europe 2025, France Pharmacology 2025, France PHARMACEUTICAL SCIENCES 2025, France PHARMACEUTICA 2025, Germany

Asia Pacific & Middle East

NURSING AND HEALTH 2025, Indonesia WORLD GASTROENTEROLOGY 2025, UAE Herbal Conference 2025, UAE Dentists 2025, UAE

Canada

Advanced Chromatography 2025, Canada World Probiotics 2025, Canada Vaccines Congress-2025, Canada World Chemistry 2025, Canada

Breast Cancer 2025

About Conference

Welcome to the 15^th World Congress on Breast Cancer Scheduled during May 26-27, 2025 in Rome, Italy.

Theme: Global Perspectives on Breast Cancer Research and Care

The 15th World Congress on Breast Cancer promises to bring together leading minds in the fight against breast cancer to discuss cutting-edge research, share innovative treatments, and foster global collaborations. Following the success of previous editions, this congress will serve as a multidisciplinary platform for researchers, clinicians, policymakers, educators, and students alike.

Why Attend Breast Cancer 2025?

This year's theme reflects the forward-thinking and transformative approach required to tackle breast cancer challenges in the modern era. The congress will cover a diverse range of topics, including:

Advancements in early detection and diagnosis
Breakthroughs in treatment strategies and personalized medicine
Emerging technologies in radiation therapy
Innovations in reconstructive surgery and supportive care

Our comprehensive program includes keynote presentations by global experts, in-depth panel discussions, interactive workshops, and poster sessions showcasing the latest advancements.

Exceptional Highlights

CME-Accredited Certification
Publication Opportunities: All accepted abstracts will receive DOIs and be featured in conference proceedings and indexed journals.
Networking Excellence: Connect with professionals from academia, industry, and healthcare sectors.
Global Recognition: Certificates of Participation accredited by the International Organizing Committee.

Who Should Attend?

The congress welcomes a broad audience, including:

Breast cancer surgeons, pathologists, and radiologists
Radiation oncologists and therapists
Medical oncologists and reconstructive surgeons
Breast care nurses, researchers, and educators
Policy-makers, healthcare associations, and students

Be Part of the Change

Join us in Vancouver, a city known for its vibrant culture and breathtaking scenery, as we work together to shape the future of breast cancer care. Your participation is essential to the success of this event, driving impactful discussions and innovative solutions that will make a difference in millions of lives.

Save the dates and stay tuned for further announcements!

Sessions & Tracks

Track 1: Breast Cancer Staging

Breast cancer staging is essential to determine the extent of cancer in the body, guiding treatment decisions like chemotherapy, hormone therapy, and targeted drugs. Both medical and pathologic staging systems are utilized, with tissue samples from surgery often providing the most accurate results. In cases where surgery isn’t feasible, clinical staging is employed. Imaging technologies like CT scans, MRIs, ultrasounds, and PET scans help identify cancer's spread, while the TNM system categorizes tumors, nodes, and metastases.

Track 2: Breast Cancer Types and Etiology

Breast cancer includes several types: Ductal Carcinoma In Situ (DCIS), a non-invasive form; Invasive Ductal Carcinoma (IDC), the most common and aggressive; Invasive Lobular Carcinoma (ILC), starting in milk glands; and rarer forms like Inflammatory Breast Cancer (IBC), Medullary, Mucinous, and Tubular Carcinoma. Its etiology includes genetic factors (BRCA mutations), hormonal influences, family history, age, and lifestyle choices (e.g., alcohol, obesity). Environmental exposures and radiation also increase the risk, with early menstruation and hormone replacement therapy contributing to higher susceptibility.

Track 3: Breast Cancer Awareness

Breast cancer awareness plays a vital role in educating the public about early detection, symptoms, and available treatments. The “pink ribbon” movement advocates for women's health, funds research, and combats the stigma surrounding breast cancer. Increased awareness can also drive support for environmental causes, with research suggesting pollution as a potential contributor to cancer rates.

Track 4: Breast Cancer Detection, Prevention, and Diagnosis

Early detection saves lives, and routine screening methods such as mammograms, clinical breast exams, and self-exams are essential. Family history plays a significant role in determining risk, and individuals should consult healthcare providers for personalized screening recommendations. Imaging advancements, including 3D mammography and ultrasounds, have improved the detection of tumors and lumps, leading to earlier diagnosis.

Track 5: Breast Cancer Risk

Age and genetics are the primary factors influencing breast cancer risk, with the majority of cases occurring in women over 50. Hereditary conditions such as BRCA1 and BRCA2 mutations increase the risk, and environmental factors, including lifestyle choices and occupational exposures, also play a part. Understanding these factors can help individuals take proactive steps to reduce risk and undergo regular screenings.

Track 6: Breast Cancer Surgery

Surgical treatment is a common part of breast cancer care, with procedures ranging from lumpectomies (breast-conserving surgery) to mastectomies. Biopsies and lymph node dissection help determine whether the cancer has spread. Post-surgery, breast reconstruction is available to restore the breast's appearance, though some patients opt for prostheses instead.

Track 7: Male Breast Cancer Research

While rare, male breast cancer is an important issue, often diagnosed late due to lack of awareness. Risk factors in men include family history, radiation exposure, and genetic conditions like Klinefelter’s syndrome. Symptoms in men are similar to those in women, and early detection is crucial for better outcomes.

Track 8: Breast Cancer and Immunology

Immunotherapy has become a key part of breast cancer treatment, helping to improve outcomes in patients with advanced or treatment-resistant cancers. By targeting specific tumor cells, immunotherapy minimizes side effects and provides more personalized treatment options. Research in this field is rapidly evolving, offering new hope to patients.

Track 9: Breast Cancer Management

Breast cancer management typically includes a combination of surgery, chemotherapy, radiotherapy, and targeted therapies. Treatment plans are tailored to the patient's specific cancer type and characteristics. New treatments, like cryoablation, offer alternatives for smaller, early-stage cancers. Reconstructive surgery is an option for those wishing to restore the breast's shape after mastectomy.

Track 10: Breast Cancer Nursing

Nurses are integral to breast cancer treatment, providing care throughout diagnosis, treatment, and recovery. They educate patients about risks, help with symptom management, and advocate for early detection. Nurses also support patients emotionally, addressing the mental health challenges that come with a breast cancer diagnosis.

Track 11: Radiology

Radiologists specialize in diagnosing breast cancer through imaging techniques like X-rays, CT scans, MRIs, and ultrasounds. Their expertise helps determine the extent of the disease and guides treatment decisions. Radiologic technologists also work closely with patients to ensure the comfort and accuracy of imaging procedures.

Track 12: Epidemiology of Breast Cancer and Risk Factors

Breast cancer's incidence increases with age, particularly after 50. Factors such as hormonal exposure, genetic mutations, and lifestyle choices like physical inactivity and alcohol use contribute to the risk. Understanding these risk factors is essential for prevention, early detection, and personalized care.

Track 13: Inflammatory Breast Cancer

Inflammatory breast cancer is a rare but aggressive form of the disease, characterized by rapid swelling, redness, and skin changes. It is often diagnosed at advanced stages, as it typically spreads quickly. Early recognition of symptoms and prompt treatment are crucial for better prognosis.

Track 14: Mammography

Mammography is a vital screening tool for early breast cancer detection, even in women with no symptoms. Screening mammograms involve taking X-ray images of the breast to identify abnormalities such as microcalcifications, which may indicate cancer. Diagnostic mammograms are used for further investigation if initial screenings reveal any concerns.

Track 15: Diet and Lifestyle Effects on Breast Cancer

A healthy lifestyle, including a balanced diet and regular physical activity, can help reduce breast cancer risk. Smoking, excessive alcohol, and being overweight are linked to higher risk, while breastfeeding, physical activity, and a plant-based diet can offer protection. Hormone replacement therapy and oral contraceptive use may increase the risk.

Track 16: Breast Cancer and Cell Biology

Breast cancer cells are often resistant to treatment due to mutations and abnormal cellular behavior. Membrane transporters play a role in drug resistance, impacting the effectiveness of chemotherapy and targeted therapies. Understanding these biological factors is key to developing new treatments that can overcome resistance and improve patient outcomes.

Track 17: Breast Cancer Clinical Trials

Clinical trials are critical to advancing breast cancer treatment, testing new drugs, therapies, and combinations. By participating in clinical trials, patients help improve treatment options for future generations. These trials also focus on risk reduction, diagnosis, and new methods of care.

Track 18: Case Studies

Case studies offer detailed insights into individual breast cancer experiences, providing valuable lessons for both patients and healthcare providers. They highlight various factors such as early detection, treatment responses, and recovery challenges, contributing to improved understanding and management of the disease.

Market Analysis

In 2024, the global breast cancer therapeutics market continues to grow rapidly, building on its valuation of $34 billion in 2023 and projected to reach $66 billion by 2032, with a steady CAGR of 6.8%. This growth is fueled by an increasing global incidence of breast cancer, coupled with advancements in treatment modalities and rising public awareness through health campaigns?Breast cancer therapeutics can be defined as the treatment or management of breast cancer using therapeutic approach & drugs such as the targeted therapy, chemotherapy, hormonal therapy, and other therapeutics. These therapeutics abduct the growth and multiplication of cancerous cells by disrupting certain proteins or DNA.

Targeted therapies remain at the forefront, dominating over 77% of the therapy segment as of 2023. Drugs like HER2 inhibitors (e.g., trastuzumab) and CDK4/6 inhibitors are highly preferred due to their ability to minimize side effects while significantly improving patient outcomes. Immunotherapies, including checkpoint inhibitors, are also gaining prominence, particularly for aggressive subtypes like triple-negative breast cancer. These therapies are advancing alongside biomarker-driven precision medicine, enabling more personalized approaches to treatment?Moreover, adoption of breast cancer awareness campaigns by public organizations is projected to promote the education regarding breast cancer and breast cancer therapeutics. For instance, the National Breast Cancer Foundation initiated “October as a Breast Cancer Awareness Month”, a campaign to drive awareness concerning the impact of breast cancer. Such initiatives are expected to encourage the diagnosed breast cancer patients to opt for optimal breast cancer therapeutics, further driving the survival rate of breast cancer therapeutics.

Geographically, North America leads the market, supported by advanced healthcare systems, extensive research funding, and a robust pipeline of FDA-approved therapies. In contrast, the Asia-Pacific region is witnessing the fastest growth, attributed to increasing healthcare investments, government-backed screening programs, and greater public awareness. European countries also maintain a significant share due to favorable policies and established healthcare infrastructure?

Public and government initiatives play a pivotal role in the market's expansion. Campaigns like Breast Cancer Awareness Month and subsidized mammogram screenings have improved early diagnosis rates, which correlate with survival probabilities exceeding 90% for early-stage breast cancer. These efforts, combined with AI and genomic tools, are transforming diagnosis and treatment landscapes?

Despite these advancements, the market faces challenges, including high treatment costs and unequal access to therapies in low-income countries. However, the emergence of generic drugs and international collaborations is gradually addressing these disparities, ensuring broader access to life-saving treatments?

U.S. breast cancer therapeutics market is anticipated to surpass USD 15.8 billion by 2028. This dominant market share is attributable to several factors such as the high incidence of breast cancer, steadily rising disease burden, and presence of major market players among others. According to the Breast Cancer Organizations statistics, as of January 2022, breast cancer affects more than 3.8 million American women. The statistics indicate that in the year 2022, around 30% of newly diagnosed cancers among women are estimated to be breast cancer cases.

Target Audience

Oncologists – Specialists in cancer diagnosis and treatment.
Radiologists – Experts in imaging techniques like mammograms and MRIs for breast cancer detection.
Surgeons – Especially breast surgeons and surgical oncologists involved in tumor removal.
Pathologists – Professionals analyzing tissue samples for accurate diagnosis.
Radiation Therapists – Specialists in radiation therapy for treating breast cancer.
Medical Researchers – Scientists exploring new treatments, diagnostics, or breast cancer biology.
Genetic Counselors – Experts assisting patients with genetic risk factors (e.g., BRCA mutations).
Nurses – Particularly oncology or breast care nurses providing direct patient care.
Pharmaceutical Professionals – Developers of drugs and targeted therapies for breast cancer.
Palliative Care Specialists – Focused on improving quality of life for advanced-stage patients.
Health Policy Makers – Professionals shaping guidelines for breast cancer screening and care.
Primary Care Physicians – Often the first to detect symptoms and refer patients.
Clinical Trial Coordinators – Managing trials for new treatments and therapies.
Patient Advocates – Representing the voice and concerns of breast cancer patients.
Public Health Experts – Focusing on breast cancer awareness, prevention, and education campaigns.

Past Conference Report

Breast Cancer 2024

We are thankful to all our wonderful Speakers, Conference Attendees, Students and Associations for making Breast Cancer 2024 Conference the best ever!

14^th World Congress on Breast Cancer was held on November 28-29, 2024 in Paris, France based on the theme “Exploring New Frontiers in Breast Cancer and Therapies". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Breast Cancer who made this event an outstanding success.

Conference Series LLC Ltd expresses its gratitude to all the participants who made this event grad success.

Conference Series LLC Ltd offers its heart felt appreciation to keynote speakers, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interweaved with the organization and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Breast Cancer 2024, Conference Series LLC Ltd would like to announce the commencement of the “15th World Congress on Breast Cancer” to be held in May 26-27, 2025 at Rome, Italy. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Breast Cancer.

Mark your calendars for the upcoming Conference; we are hoping to see you soon!

Let us meet again @ Breast Cancer 2025

For More details visit: https://breastcancer.conferenceseries.com/

Past Reports Gallery